growth driven by lifestyle fibers growth in India (IRSL). IVL reported US$281M of core EBITDA registering a more pronounced decline yoy as spreads came off from a strong 3Q18. IVL reported US$405M of OCF
: 1. Sales Revenue 1.1 Sales revenue for the 3-months period ended 31 October 2019 For the 3-months period ended 31 October 2019, INGRS registered sales revenue of Baht 695.34 million, a decrease by
subsidiaries for 1Q21 at Baht 1,463 million, an increase of 32.0% from the previous quarter. When comparing to 1Q20, net profit decline slightly by 1.4%. The consolidated comprehensive income for 1Q21 totaled
) Total Liabilities Total liability as of December 31, 2018 was 106.34 mb, a decrease of 5.33 mb or 4.8%. The decline is due to the quicker payment to supplier and financial leasing. (c) Shareholders
million. Administrative Expenses Administrative expenses accounted for Baht 49.98 million in 2019, a year-on-year decline of Baht 0.28 million. This resulted largely from bonus foregone by an executive of
decline of Baht 0.28 million. This resulted largely from bonus foregone by an executive of Baht 2.25 million; an increase in salary of Baht 5.5 million due to the yearly salary base adjustment and the
consolid ecrease 5.8 017, the gr rom the sam gross profit es which yie arter of 201 vious year ection servic on of purch 0.8 percent a result of e decrease me revenue pany’s total ent from the unt receivab
achieve the target especially in second half of the year due to the decline of Chinese tourists and economic slowdown in several countries especially in Europe which negatively affect spending power of
promising growth was attributed by the increase of number of patients as well as bill amount per patient. A yoy slight decline of social security revenue were mainly from high care cost revenue following the